Altre lingue MINAPHARM Pharmaceuticals

Azioni

MIPH

EGS380G1C011

Prezzo di chiusura Egyptian Exchange Altri mercati azionari 00:00:00 16/05/2024			Variaz. 5gg	Var. 1 gen.
200,3 ^EGP	0,00%		0,00%	-8,00%

07/04	MINAPHARM Pharmaceuticals riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI
2023	MINAPHARM Pharmaceuticals riporta i risultati degli utili per il secondo trimestre e i sei mesi conclusi il 30 giugno 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

MINAPHARM Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2023	07/04
SaudiVax, Minapharm, and MiGenTra Sign a Memorandum of Understanding towards a Strategic Partnership in Saudi Arabia and the Gulf Cooperation Countries	05/10/23
SaudiVax, Minapharm, and MiGenTra Sign a Memorandum of Understanding towards a Strategic Partnership in Saudi Arabia and the Gulf Cooperation Countries This landmark MOU marks a significant step towards ensuring national health security and achieving biomanufacturing autonomy in Saudi Arabia	04/10/23
MINAPHARM Pharmaceuticals Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/08/23
MINAPHARM Pharmaceuticals Reports Earnings Results for the First Quarter Ended March 31, 2023	29/05/23
MINAPHARM Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23
Participants Dosed of Adessia® in Germany in a Phase 1 Trial, a First for an Adalimumab Biosimilar Candidate Developed in Africa	06/03/23
Participants Dosed of Adessia® in Germany in a Phase 1 Trial, a First for an Adalimumab Biosimilar Candidate Developed in Africa This follows a prior announcement made by Minapharm Pharmaceuticals on February 13, 2023 reporting that said Phase 1 trial received unconditional approval from the Paul-Ehrlich Institut (PEI)	06/03/23
Bioventure, Minapharm Pharmaceuticals and Migentra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa	30/11/22
Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa	29/11/22
Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa According to the agreement, Minapharm Pharmaceuticals and MiGenTra GmbH will share responsibilities in the Territory to file, launch and commercialize Alvotech's portfolio of licensed biosimilars once approved	29/11/22
MINAPHARM Pharmaceuticals Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	29/11/22
MINAPHARM Pharmaceuticals Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/08/22
MINAPHARM Pharmaceuticals Reports Earnings Results for the First Quarter Ended March 31, 2022	02/06/22
MINAPHARM Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2021	31/03/22
MINAPHARM Pharmaceuticals Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	30/11/21
MINAPHARM Pharmaceuticals Reports Consolidated Earnings Results for the Six Months Ended June 30, 2021	31/08/21
MINAPHARM Pharmaceuticals Reports Standalone Earnings Results for the Six Months Ended June 30, 2021	12/08/21
MINAPHARM Pharmaceuticals Announces Consolidated Earnings Results for the Quarter Ended March 31, 2021	16/06/21
ProBioGen AG and MINAPHARM Pharmaceuticals Incorporate MiGenTra GmbH - A Healthcare Transforming Medicines Company	27/05/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue MINAPHARM Pharmaceuticals

Azioni

MIPH

EGS380G1C011

Altre lingue

Filtri